Revenue
2015
2016
2017
2018
2019
2020
2021
2022
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥3.24T | ¥2.61T | ¥1.93T | ¥2.52T | ¥2.37T | ¥2.03T | ¥1.62T | ¥1.73T |
| Research & development | ¥20.02B | ¥16.73B | ¥15.75B | ¥15.67B | ¥14.09B | ¥12.32B | ¥11.23B | ¥11.86B |
| Operating income | ¥216.66B | ¥161.15B | ¥75.94B | ¥121.76B | ¥122.94B | ¥70.84B | ¥60.63B | ¥79.25B |
| Net income | ¥149.38B | ¥92.17B | ¥19.01B | ¥45.68B | ¥53.04B | ¥23.54B | ¥7.86B | ¥35.52B |
| Basic EPSper diluted share | — | — | CN¥0.10 | CN¥0.25 | CN¥0.29 | CN¥0.13 | CN¥0.04 | CN¥0.19 |
| Diluted EPSper diluted share | — | — | CN¥0.10 | CN¥0.25 | CN¥0.29 | CN¥0.13 | CN¥0.04 | CN¥0.19 |